Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Getinge Capital/Financing Update 2013

May 15, 2013

2917_rns_2013-05-15_ca610f5a-c58d-4035-9199-42502d53d797.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

PRESS RELEASE 15 May 2013

Getinge issues five year bonds

Getinge AB has raised SEK 2 billion through issuance of notes with a five year maturity. SEK 1.5 billion has been issued as a Floating Rate Note with a spread of +1.88% over three month STIBOR. SEK 0.5 billion was issued as a Fixed Rate Note with a coupon rate at 3.5%. The proceeds from the loan will be used to refinance the Therapeutic Support Systems (TSS) acquisition debt. The arranging banks were Danske Bank, Nordea and SEB.

For further information, please contact:

Ulf Grunander CFO, Getinge Group

Phone: +46 (0)10 335 5580 E-mail: [email protected]

GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency in healthcare, care and research. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control in healthcare and contamination prevention in biotechnology. MAQUET specializes in solutions, therapies and products for surgical interventions and intensive care.

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 11 AM (CET) on 15th of May, 2013.